These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37222453)

  • 1. Chemogenetic modulation of astrocytes and microglia: State-of-the-art and implications in neuroscience.
    Bossuyt J; Van Den Herrewegen Y; Nestor L; Buckinx A; De Bundel D; Smolders I
    Glia; 2023 Sep; 71(9):2071-2095. PubMed ID: 37222453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-by-side comparison of the effects of Gq- and Gi-DREADD-mediated astrocyte modulation on intracellular calcium dynamics and synaptic plasticity in the hippocampal CA1.
    Van Den Herrewegen Y; Sanderson TM; Sahu S; De Bundel D; Bortolotto ZA; Smolders I
    Mol Brain; 2021 Sep; 14(1):144. PubMed ID: 34544455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs.
    Burnett CJ; Krashes MJ
    J Neurosci; 2016 Sep; 36(36):9268-82. PubMed ID: 27605603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemogenetic stimulation of the G
    Kim JH; Rahman MH; Lee WH; Suk K
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00822. PubMed ID: 34676988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Vector Delivery of DREADDs for CNS Therapy.
    Pickering CA; Mazarakis ND
    Curr Gene Ther; 2021; 21(3):191-206. PubMed ID: 33573551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats.
    Campbell EJ; Marchant NJ
    Br J Pharmacol; 2018 Apr; 175(7):994-1003. PubMed ID: 29338070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemogenetic and Optogenetic Manipulations of Microglia in Chronic Pain.
    Parusel S; Yi MH; Hunt CL; Wu LJ
    Neurosci Bull; 2023 Mar; 39(3):368-378. PubMed ID: 35976535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DREADDed microglia in pain: Implications for spinal inflammatory signaling in male rats.
    Grace PM; Wang X; Strand KA; Baratta MV; Zhang Y; Galer EL; Yin H; Maier SF; Watkins LR
    Exp Neurol; 2018 Jun; 304():125-131. PubMed ID: 29530713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
    Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
    Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Behavioral Manipulation via Orally Delivered Chemogenetic Actuator in Macaques.
    Oyama K; Hori Y; Nagai Y; Miyakawa N; Mimura K; Hirabayashi T; Inoue KI; Takada M; Higuchi M; Minamimoto T
    J Neurosci; 2022 Mar; 42(12):2552-2561. PubMed ID: 35110390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemogenetic Signaling in Space and Time: Considerations for Designing Neuroscience Experiments Using DREADDs.
    Clark PJ; Brodnik ZD; España RA
    Neuroscientist; 2024 Jun; 30(3):328-346. PubMed ID: 36408535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemogenetic manipulation of astrocyte activity at the synapse- a gateway to manage brain disease.
    Pereira MJ; Ayana R; Holt MG; Arckens L
    Front Cell Dev Biol; 2023; 11():1193130. PubMed ID: 37534103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting-State fMRI-Based Screening of Deschloroclozapine in Rhesus Macaques Predicts Dosage-Dependent Behavioral Effects.
    Fujimoto A; Elorette C; Fredericks JM; Fujimoto SH; Fleysher L; Rudebeck PH; Russ BE
    J Neurosci; 2022 Jul; 42(29):5705-5716. PubMed ID: 35701162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.
    Dambach H; Hinkerohe D; Prochnow N; Stienen MN; Moinfar Z; Haase CG; Hufnagel A; Faustmann PM
    Epilepsia; 2014 Jan; 55(1):184-92. PubMed ID: 24299259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice.
    Yi MH; Liu YU; Liu K; Chen T; Bosco DB; Zheng J; Xie M; Zhou L; Qu W; Wu LJ
    Brain Behav Immun; 2021 Feb; 92():78-89. PubMed ID: 33221486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility.
    Urban DJ; Roth BL
    Annu Rev Pharmacol Toxicol; 2015; 55():399-417. PubMed ID: 25292433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of DREADDs to Deconstruct Behavior.
    Whissell PD; Tohyama S; Martin LJ
    Front Genet; 2016; 7():70. PubMed ID: 27242888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DREADDS: Use and application in behavioral neuroscience.
    Smith KS; Bucci DJ; Luikart BW; Mahler SV
    Behav Neurosci; 2016 Apr; 130(2):137-55. PubMed ID: 26913540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemogenetic manipulation of astrocytic activity: Is it possible to reveal the roles of astrocytes?
    Shen W; Chen S; Liu Y; Han P; Ma T; Zeng LH
    Biochem Pharmacol; 2021 Apr; 186():114457. PubMed ID: 33556341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain.
    Aldrin-Kirk P; Björklund T
    Methods Mol Biol; 2019; 1937():59-87. PubMed ID: 30706390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.